Pelthos Therapeutics Inc.
PTHS- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001919246
In the last 90 days, Pelthos Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $37.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pelthos Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 3 insiders, $55.9K in total
- Insiders trading
- 3
- Net value
- −$55.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pelthos Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Friedberg Ezra M | Director | 81,042 | Jul 7, 2026 | 6 |
| Pauls Matthew | Director | 14,364 | Jul 7, 2026 | 4 |
| Greenleaf Peter | Director | 23,884 | Jul 7, 2026 | 3 |
| Davis Todd C | Director | 75,834 | Jun 15, 2026 | 2 |
| Francis Knuettel II | CFO, Treas & Secty | 11,316Indirect | May 26, 2026 | 2 |
| Malamut Richard | Director | 27,422 | Apr 6, 2026 | 2 |
| Plesha Scott M. | CEO and President | 83,678 | Apr 1, 2026 | 1 |
| Baxter Richard B | Director | 19,108 | Apr 1, 2026 | 1 |
| Rangarao Sai | Chief Commercial Officer | 30,518 | Apr 1, 2026 | 1 |
| Einhorn Andrew J. | Director | 12,000 | Dec 29, 2025 | 1 |
| Ligand Pharmaceuticals Inc | Director, 10% Owner | 1,500,000 | Dec 19, 2025 | 2 |
| Simmons Chia-Lin | Director | – | Apr 15, 2025 | 0 |
| Lang Eric | Chief Medical Officer | – | Jun 18, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)5:03 PM ET | Jul 2 | 5 days | Friedberg Ezra MDirector | SSale | −558 | $26.09 | −$14.6K | −0.7%81.0K after | 2 lots10b5-1 |
| Jul 7, 2026 (view filing)5:03 PM ET | Jul 2 | 5 days | Pauls MatthewDirector | SSale | −786 | $26.16 | −$20.6K | −5.2%14.4K after | 2 lots10b5-1 |
| Jul 7, 2026 (view filing)5:03 PM ET | Jul 2 | 5 days | Greenleaf PeterDirector | SSale | −797 | $26.13 | −$20.8K | −3.2%23.9K after | 2 lots10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Friedberg Ezra MDirector | SSale | −283 | $27.29 | −$7.72K | −0.3%81.6K after | 2 lots10b5-1 |
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Davis Todd CDirector | PPurchase | +35.9K | $27.81 | +$999.8K | +90.1%75.8K after | 2 lots |
| May 26, 2026 (view filing) | May 22 | 4 days | Francis Knuettel IICFO, Treas & Secty | SSale | −1.50K | $26.84 | −$40.3K | −11.7%11.3K after | |
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Malamut RichardDirector | SSale | −590 | $20.91 | −$12.3K | −2.1%27.4K after | 2 lots10b5-1 |
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Friedberg Ezra MDirector | SSale | −558 | $20.91 | −$11.7K | −0.7%82.0K after | 2 lots10b5-1 |
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Pauls MatthewDirector | SSale | −786 | $20.92 | −$16.4K | −4.9%15.2K after | 2 lots10b5-1 |
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Greenleaf PeterDirector | SSale | −797 | $20.92 | −$16.7K | −3.1%24.7K after | 2 lots10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Friedberg Ezra MDirector | SSale | −10.0K | $28.03 | −$280.3K | −25.0%30.0K after | 4 lots |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Friedberg Ezra MDirector | PPurchase | +132.1K | $0.00 | $0 | –40.0K after | Derivative2 lots |
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | Malamut RichardDirector | PPurchase | +10.4K | $0.94 | +$9.78K | +12.8%91.6K after | |
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Francis Knuettel IICEO, Pres., CFO, Treas & Secty | PPurchase | +5.20K | $0.97 | +$5.04K | +1.0%547.7K after | 2 lots |
| Sep 12, 2024 (view filing) | Sep 10-11 | 2 days | Francis Knuettel IICEO, Pres., CFO, Treas & Secty | PPurchase | +12.0K | $0.9129 | +$11.0K | +2.3%542.5K after | 2 lots |
| Mar 12, 2024 (view filing) | Feb 21 | 20 days | Friedberg Ezra MDirector | PPurchase | +16.7K | $6.00 | +$100.0K | +3.2%545.7K after | Amended |